A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SERTRALINE VS. PLACEBO IN THE TREATMENT OF ANXIETY IN CHILDREN AND ADOLESCENTS WITH NEURODEVELOPMENTAL DISORDERS

Registry ID

SER-11-2020

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

DR EVDOKIA ANAGNOSTOU

Start date

2024-04-01

Last update

2021-03-16

Conditions

• AUTISM SPECTRUM DISORDER
• ANXIETY DISORDER

Related clinical trials

• PSILOCYBIN-ASSISTED EXISTENTIAL, ATTACHMENT AND RELATIONAL (PEARL) THERAPY FOR CAREGIVERS OF PATIENTS WITH ADVANCED CANCER: A PHASE II OPEN-LABEL TRIAL
• PSILOCYBIN FOR TREATMENT-RESISTANT DEPRESSION IN AUTISM: A PILOT TRIAL WITH PRE-POST BRAIN AND COGNITIVE MEASUREMENT TO UNDERSTAND MECHANISMS (PAT-DA)
• A PHASE 2A, PLACEBO-CONTROLLED RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF PSILOCYBIN ORAL SOLUTION IN ADULTS WITH GENERALIZED ANXIETY DISORDER
• AN OPEN-LABEL EXTENSION STUDY TO INVESTIGATE SAFETY AND TOLERABILITY OF ML-004 IN ADOLESCENTS AND ADULTS WITH AUTISM SPECTRUM DISORDER (ASD)
• IMAGING ALTERATIONS IN SYNAPTIC DENSITY IN AUTISM SPECTRUM DISORDER USING A NOVEL SYNAPTIC VESICULAR PROTEIN 2A TRACER [18F]SYNVEST-1
• DEEP BRAIN STIMULATION FOR THE TREATMENT OF REFRACTORY REPETITIVE SELF-INJURIOUS BEHAVIOUR IN CHILDREN WITH AUTISM SPECTRUM DISORDER. A PILOT PROJECT.

View on source registry